Trial intelligence / Profile preview

Pregabalin vs gabapentin combined with NSAIDs for postoperative pain after spinal surgery

ChiCTR2000035554Phase 4Recruiting

Sponsor
First Affiliated Hospital of Chongqing Medical University
Start
Aug 2020
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of pregabalin, gabapentin, celecoxib and parecoxib in degenerative disc disease (DDD), Herniated Lumbar Disk, lumbar spinal stenosis (LSS) and 2 more (4 arms), sponsored by First Affiliated Hospital of Chongqing Medical University. Primary endpoints: VAS scores and PCA dose. Started Aug 2020; status: recruiting.

02

Drugs

pregabalingabapentincelecoxibparecoxib
03

Conditions

degenerative disc disease (DDD)Herniated Lumbar Disklumbar spinal stenosis (LSS)lumbar spondylolisthesisvertebral compression fracture (VCF)

Beyond the preview

Go deeper on ChiCTR2000035554.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000035554.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call